EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”) between APREA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Scott M. Coiante (the “Executive”), is made and entered into as of September 26, 2019, and will become effective, if at all, upon the date of closing of the Company’s initial public offering of stock pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations
July 15, 2016 Greg Korbel Philadelphia, PA 19129 Dear Greg:Aprea Therapeutics, Inc. • September 27th, 2019 • Pharmaceutical preparations • Delaware
On behalf of Aprea (US), Inc. (the “Company”), a wholly-owned U.S. subsidiary of Aprea AB (“Aprea”), I am pleased to confirm the terms and conditions of your employment as set forth below in this letter agreement (this “Agreement”). Certain capitalized terms used in this Agreement without definition are defined in Section 14.
FORM OF EMPLOYMENT AGREEMENTForm of Employment Agreement • September 27th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”) between APREA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [ ] (the “Executive”), is made and entered into as of [ , 20 ] (the “Effective Date”).
